Adaptin Bio (APTN) Notes Payables (2022 - 2024)

Adaptin Bio has disclosed Notes Payables across 3 years of filings, most recently posting $275000.0 for Q4 2024.

• Notes Payables for Q4 2024 came in at $275000.0, up 238.59% year-over-year; the trailing twelve-month figure through Dec 2024 was $275000.0 (up 238.59% YoY), and the FY2024 annual result was $275000.0, up 238.59% from the prior year.
• Notes Payables came in at $275000.0 for Q4 2024 at Adaptin Bio, up from $137764.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $275000.0 in Q4 2024 to a low of $5000.0 in Q4 2022.
• The 3-year median for Notes Payables is $81219.0 (2023), against an average of $102235.1.
• Across the five-year window, Notes Payables jumped 1524.38% in 2023 and surged 238.59% in 2024, its largest moves.
• Adaptin Bio's Notes Payables stood at $5000.0 in 2022, then surged by 1524.38% to $81219.0 in 2023, then soared by 238.59% to $275000.0 in 2024.
• The last three Notes Payables figures came in at $275000.0 (Q4 2024), $137764.0 (Q3 2024), and $112572.0 (Q2 2024), per Business Quant data.